Rion Co., Ltd. (JP:6823)
:6823
6823 Stock Chart & Stats
¥2691.00
-¥68.00(-2.64%)
At close: 4:00 PM EST
¥2691.00
-¥68.00(-2.64%)
Day’s Range― - ―
52-Week Range¥1,952.00 - ¥3,145.00
Previous CloseN/A
Volume32.10K
Average Volume (3M)26.46K
Market Cap
¥35.06B
Enterprise Value¥28.93B
Total Cash (Recent Filing)¥6.16B
Total Debt (Recent Filing)¥1.73B
Price to Earnings (P/E)10.2
Beta1.11
Next Earnings
Apr 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.93%
Share Statistics
EPS (TTM)64.65
Shares Outstanding12,347,700
10 Day Avg. Volume21,140
30 Day Avg. Volume26,463
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)0.96
Price to Sales (P/S)1.09
P/FCF Ratio14.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)275.7
Revenue Forecast (FY)¥29.50B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 61% revenue increase in the latest year indicates durable demand for Rion’s measurement and medical devices across industrial, environmental and healthcare markets. Such sustained top-line growth supports reinvestment in R&D, expands market share, and provides a foundation for multi-year earnings improvement and product ecosystem expansion.
Strong Cash GenerationImproving free cash flow and a strong operating cash flow to net income ratio signal reliable internal funding for capex, product development, and dividends without heavy external financing. Persistent cash conversion strengthens financial flexibility and resilience across business cycles, enabling strategic investments and shareholder returns.
Low Leverage / Solid Balance SheetA very low debt-to-equity ratio and a healthy equity ratio reduce financial risk and interest burden, providing capacity to invest or weather downturns. Combined with stable ROE (~9%), the conservative capital structure supports stable operations, disciplined growth, and the ability to pursue strategic opportunities without straining liquidity.
Bears Say
Gross Margin CompressionA slight decline in gross margin from ~50% suggests rising input costs or pricing pressure in core hardware businesses. If structural, continued margin compression would erode operating leverage and constrain reinvestment capacity, reducing long-term profitability even if revenue growth remains strong.
Moderate ROEROE around 9% reflects moderate capital efficiency for a technology and medical-equipment manufacturer. While stable, this level may limit long-term shareholder returns relative to higher-return peers and suggests the company must rely on growth or margin expansion rather than superior asset efficiency to drive substantial shareholder value.
Hardware-Dependent Revenue MixA revenue base concentrated in hardware product sales implies greater cyclicality and lumpiness versus recurring software or service models. Dependence on transactional sales increases exposure to capex cycles and competitive pricing, reducing revenue predictability and making long-term margin stability more sensitive to demand swings.
Rion Co., Ltd. News
6823 FAQ
What was Rion Co., Ltd.’s price range in the past 12 months?
Rion Co., Ltd. lowest stock price was ¥1952.00 and its highest was ¥3145.00 in the past 12 months.
What is Rion Co., Ltd.’s market cap?
Rion Co., Ltd.’s market cap is ¥35.06B.
When is Rion Co., Ltd.’s upcoming earnings report date?
Rion Co., Ltd.’s upcoming earnings report date is Apr 24, 2026 which is in 26 days.
How were Rion Co., Ltd.’s earnings last quarter?
Rion Co., Ltd. released its earnings results on Jan 29, 2026. The company reported ¥64.65 earnings per share for the quarter, beating the consensus estimate of N/A by ¥64.65.
Is Rion Co., Ltd. overvalued?
According to Wall Street analysts Rion Co., Ltd.’s price is currently Overvalued.
Does Rion Co., Ltd. pay dividends?
Rion Co., Ltd. pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 2.93%. See more information on Rion Co., Ltd. dividends here
What is Rion Co., Ltd.’s EPS estimate?
Rion Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rion Co., Ltd. have?
Rion Co., Ltd. has 12,347,700 shares outstanding.
What happened to Rion Co., Ltd.’s price movement after its last earnings report?
Rion Co., Ltd. reported an EPS of ¥64.65 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.146%.
Which hedge fund is a major shareholder of Rion Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6823
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rion Co., Ltd.
Rion Co., Ltd. manufactures, sells, and maintains hearing instruments, medical equipment, sound and vibration measuring instruments, particle counters, and related parts and equipment in Japan. The company's audiological equipment includes hearing instruments, such as analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom made, and analog body aid instruments, as well as waterproof hearing instruments; and medical equipment comprising audiometers and OAE screeners. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, recorders, and other products. The company's particle counters comprise air and liquid- borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---